世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039541

ペプチド合成市場:規模、シェア、動向分析レポート、およびセグメント予測、2024〜2030

Grand View Research Inc.

Peptide Synthesis Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2024- 2030

発刊日 2024/09

言語英語

体裁PDF/100ページ

ライセンス/価格100ページ

0000039541

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

ペプチド合成の市場規模、シェア、動向分析レポート:製品別 (機器、試薬、消耗品)、用途別 (治療薬、診断)、技術別、最終用途別、地域別、セグメント別予測、2024-2030

ペプチド合成の市場規模と動向

世界のペプチド合成市場の規模は2023年に6億800万ドルと評価され、2024年から2030年にかけて12.7%のCAGRで成長すると予測されます。ペプチドベースの治療薬の需要の増加、診断およびイメージングにおける用途の拡大、希少疾患の治療薬、個別化医療、精密治療薬の進歩などがこの市場の成長を促進しています。さらに、より高い遺伝活性、広範な化学物質、低毒性、および高い特異性によって市場の成長が加速しています。

レポート詳細

目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Peptide Synthesis Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Peptide Synthesis Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Peptide Synthesis Market: product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Peptide Synthesis Market Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Equipment
4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Peptide Synthesizers
4.3.2.1. Peptide Synthesizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Lyophilizers
4.3.3.1. Lyophilizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Chromatography Equipment
4.3.4.1. Chromatography Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Others
4.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Reagents & Consumables
4.4.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Resins
4.4.2.1. Resins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Amino Acids
4.4.3.1. Amino Acids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Coupling Reagents
4.4.4.1. Coupling Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Dyes & Fluroscent Labeling Reagents
4.4.5.1. Dyes & Fluroscent Labeling reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.6. Others
4.4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Peptide Synthesis Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Peptide Synthesis Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
5.3. Solid Phase Peptide Synthesis (SPPS)
5.3.1. Solid Phase Peptide Synthesis (SPPS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Liquid Phase Peptide Synthesis (LPPS)
5.4.1. Liquid Phase Peptide Synthesis (LPPS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Hybrid Technology
5.5.1. Hybrid Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Peptide Synthesis Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Peptide Synthesis Market: Application Movement Analysis, 2023 & 2030 (USD Million)
6.3. Therapeutics
6.3.1. Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. Cancer
6.3.2.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Metabolic
6.3.3.1. Metabolic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. Cardiovascular Disorder
6.3.4.1. Cardiovascular Disorder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Respiratory
6.3.5.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. GIT (Gastrointestinal Disorders)
6.3.6.1. GIT (Gastrointestinal Disorders) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Infectious Diseases
6.3.7.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Pain
6.3.8.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Dermatology
6.3.9.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.10. CNS
6.3.10.1. CNS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.11. Renal
6.3.11.1. Renal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.12. Others
6.3.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Diagnosis
6.4.1. Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Research
6.5.1. Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Peptide Synthesis Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Peptide Synthesis Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
7.3. Pharmaceutical & Biotechnology Companies
7.3.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Contract Development & Manufacturing Organization/Contract Research Organization
7.4.1. Contract Development & Manufacturing Organization/Contract Research Organization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Academic & Research Institutes
7.5.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Peptide Synthesis Market: Regional Estimates & Trend Analysis
8.1. Peptide Synthesis Market Share, By Region, 2023 & 2030, USD Million
8.2. North America
8.2.1. North America Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. China
8.4.2.1. China Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. Japan
8.4.3.1. Japan Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. South Korea Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Australia Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. Saudi Arabia
8.6.2.1. Saudi Arabia Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. UAE
8.6.3.1. UAE Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. South Africa
8.6.4.1. South Africa Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/Strategic Initiatives
9.4.2. Merck KGaA
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/Strategic Initiatives
9.4.3. GenScript
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/Strategic Initiatives
9.4.4. Bachem Holding AG
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/Strategic Initiatives
9.4.5. Biotage
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/Strategic Initiatives
9.4.6. Creative Diagnostics
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/Strategic Initiatives
9.4.7. PolyPeptide Group
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/Strategic Initiatives
9.4.8. Syngene International Limited
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/Strategic Initiatives
9.4.9. Puresynth Research Chemicals Pvt Ltd.
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/Strategic Initiatives
9.4.10. Lonza
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/Strategic Initiatives

この商品のレポートナンバー

0000039541

TOP